VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,850,900 | +28.9% | 215,000 | +121.9% | 0.38% | +32.4% |
Q1 2022 | $2,212,000 | -86.5% | 96,912 | -78.1% | 0.29% | -83.0% |
Q4 2021 | $16,343,000 | -21.6% | 443,265 | 0.0% | 1.69% | +12.3% |
Q3 2021 | $20,833,000 | -54.4% | 443,265 | -41.5% | 1.50% | -60.9% |
Q2 2021 | $45,685,000 | – | 758,265 | – | 3.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
RA Capital Management | 880,284 | $53,037,000 | 0.85% |